Published by maria gbaf
Posted on January 27, 2022
6 min readLast updated: January 28, 2026
The Liquid Biopsy Market is set to grow at a 13.49% CAGR, reaching US$ 3,637 Mn by 2031, driven by microchip technology and cancer diagnosis advancements.
[262 Pages Report] As per a recent market analysis by ESOMAR-certified firm Future Market Insights (FMI), the global Liquid Biopsy Market value is pegged to reach US$ 1,026 Mn in 2021. Rising at 13.49% CAGR the market is expected to total US$ 3,637 Mn by 2031.
To remain ‘ahead’ of your competitors, request for a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1396
As per a recent market survey by ESOMAR-certified consulting firm Future Market Insights (FMI), the global liquid biopsy market is expected to reach a market valuation of US$ 1,026 Mn in 2021.
With the introduction of innovative molecular diagnostic tests and growing demand from biotech and pharmaceutical companies, the market is poised to expand at a stellar 13.49% CAGR, reaching US$ 3,637 Mn by 2031.
Growth of the liquid biopsy market is attributable to rising incidence of cancer across several countries, which is highlighting the pressing need for faster, simpler, and more convenient diagnostic procedures. Liquid biopsy procedures are minimally invasive and cost-effective, which is making them a favorable choice for cancer diagnosis procedures.
Besides this, increasing government-backed initiatives to support cancer research across the U.S., Japan, India and the UK will drive innovation and developments in liquid biopsy services. Also, fast track approval from regulatory bodies for novel procedures will bolster the growth over the coming years.
Additionally, technological advancements such as the incorporation of machine learning and microchip-based liquid biopsy systems will further strengthen growth prospects in the market.
As per the market survey, counties including the U.S., the U.K, and Japan will be at the forefront of innovation and adoption of liquid biopsy services, owing to the presence of leading players and prevalence of numerous high-potential cancer research institutes.
Germany, India, and China will emerge as high growth potential markets, with increasing investments by the government for improving the healthcare infrastructure, which will create attractive opportunities to global biotech players for market expansion.
“Increasing incidence of cancer, coupled with incorporation of latest technology in liquid biopsy for faster and more convenient diagnosis will continue to augment the market growth throughout the forecast period,” says the FMI analyst.
For critical insights on this market, request to ask an expert here @ https://www.futuremarketinsights.com/ask-question/rep-gb-1396
Key Takeaways from the Liquid Biopsy Market Analysis
Competitive Landscape
BIOCEPT, INC., Qiagen N.V., Trovagene, Inc, Janssen Global Services, LLC, MDxHealth SA, Natera, Inc, F. Hoffmann-La Roche Ltd, Silicon Biosystems, Pathway Genomics Corporation, and Sysmex Corporation are among top manufacturers of liquid biopsy products, as profiled by FMI. As per the market survey, tier-1 companies are anticipated to account for approximately 20-25% of the total market share.
For More Information or Query or Customization Before Buying, Visit: https://www.futuremarketinsights.com/customization-available/rep-gb-1396
Strategic collaborations, partnerships, and product innovations are some of the prominent growth strategies applied by leading market players to establish a strong foothold in the liquid biopsy market. For instance:
More Insights into the Liquid Biopsy Market Report
In its latest report, FMI offers an unbiased analysis of the global liquid biopsy market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of marker type (circulating tumor cells (CTC), circulating tumor nucleic acids (cTNA) and exosomes), sample type (blood, urine and other including plasma, saliva and CSF), application type (lung cancer, gastrointestinal cancer, prostate cancer, colorectal cancer, leukemia), end-users (hospitals, cancer institutes, academic institutes, and diagnostic centers) and across seven regions (North America, Latin America, Eastern Europe, Western Europe, Asia Pacific excluding Japan (APEJ), Japan, and Middle East & Africa).
Explore Extensive Coverage of FMI’s Healthcare, Pharmaceuticals and Medical Devices Market Reports
GCC Medical Gloves Market: FMI’s extensive analysis on the GCC medical gloves market brings to the fore insights that can help stakeholders identify the opportunities and challenges associated with its expansion until 2026. The report infers that the GCC medical gloves market shall register a strong growth rate during the assessment period.
Carpal Tunnel Release Systems Market: Aligning with the growing preference for minimally invasive surgical procedures, the carpal tunnel release systems market is projected to follow a healthy growth trail, according to FMI’s recent report on the subject. The market is expected to surpass an impressive revenue threshold by 2029.
Guidewires Market: FMI’s recent report on the guidewires market highlights prominent dynamics influencing market growth prospects for the forecast period 2020-2030. It elaborates on the revenue prospects for each segment across prominent geographies for the aforementioned assessment cycle.
About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest market research reports and industry analysis help businesses navigate challenges and take critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously track emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.
Contact
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Market Report: https://www.futuremarketinsights.com/reports/liquid-biopsy-market
Press Release Source: https://www.futuremarketinsights.com/press-release/liquid-biopsy-market
The article discusses the growth of the Liquid Biopsy Market, driven by technological advancements and increasing cancer diagnosis needs.
The market is projected to grow at a 13.49% CAGR, reaching US$ 3,637 Mn by 2031, due to innovations in diagnostic procedures.
The U.S., U.K., and Japan are leading in innovation and adoption of liquid biopsy services.
Explore more articles in the Research Reports category
